Natia Dvali
Overview
Explore the profile of Natia Dvali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chkhartishvili N, Bolokadze N, Rukhadze N, Dvali N, Abutidze A, Sharvadze L, et al.
Int J STD AIDS
. 2019 Sep;
30(12):1185-1193.
PMID: 31558133
No abstract available.
2.
Karkashadze E, Dvali N, Bolokadze N, Sharvadze L, Gabunia P, Karchava M, et al.
J Med Virol
. 2018 Jun;
91(2):235-240.
PMID: 29905958
Human immunodeficiency virus (HIV) drug resistance is a major threat to the sustained impact of antiretroviral therapy (ART). We studied the epidemiology of drug resistance in the country of Georgia....
3.
Chkhartishvili N, Chokoshvili O, Bolokadze N, Tsintsadze M, Sharvadze L, Gabunia P, et al.
PLoS One
. 2017 Oct;
12(10):e0186835.
PMID: 29084276
Late presentation for HIV care has important individual and population implications. The objective of this study was to explore the problem of late presentation in the country of Georgia. Data...
4.
Karchava M, Chkhartishvili N, Sharvadze L, Abutidze A, Dvali N, Gatserelia L, et al.
Hepatol Res
. 2017 Mar;
48(1):36-44.
PMID: 28258606
Aim: Hepatitis C virus (HCV) recombinant form RF1_2k/1b is common in ethnic Georgians. This chimera virus contains genomic fragments of genotype 2 and genotype 1 and is misclassified as genotype...
5.
Chkhartishvili N, Chokoshvili O, Abutidze A, Dvali N, Del Rio C, Tsertsvadze T
AIDS Res Hum Retroviruses
. 2017 Jan;
33(10):999-1003.
PMID: 28051324
Successful engagement in HIV care is required to reach UNAIDS targets of 90-90-90. We analyzed routine programmatic data to quantify losses along the HIV care continuum in the country of...
6.
Chkhartishvili N, Chokoshvili O, Dvali N, Abutidze A, Sharvadze L, Tsertsvadze T
J Int Assoc Provid AIDS Care
. 2016 Sep;
15(6):451-454.
PMID: 27629869
The objective of this report was to assess Georgia's progress toward Joint United Nations Programme on HIV/AIDS 90-90-90 targets over the period between 2011 and 2015. The number of HIV-positive...
7.
Karchava M, Waldenstrom J, Parker M, Hallack R, Sharvadze L, Gatserelia L, et al.
Hepatol Res
. 2015 Feb;
45(13):1292-8.
PMID: 25689487
Aim: The first hepatitis C virus (HCV) recombinant, RF2k/1b, was initially described from Russia and has since then been identified from patients in Ireland, Estonia, Uzbekistan and Cyprus. Many of...
8.
Akhvlediani T, Bautista C, Shakarishvili R, Tsertsvadze T, Imnadze P, Tatishvili N, et al.
PLoS One
. 2014 Nov;
9(11):e111393.
PMID: 25369023
Objectives: There is a large spectrum of viral, bacterial, fungal, and prion pathogens that cause central nervous system (CNS) infections. As such, identification of the etiological agent requires multiple laboratory...
9.
Chkhartishvili N, Sharvadze L, Dvali N, Karchava M, Rukhadze N, Lomtadze M, et al.
AIDS Res Ther
. 2014 Jul;
11:18.
PMID: 25035708
Background: Data on the effectiveness of second-line antiretroviral therapy (ART) in resource-limited countries of Eastern Europe is limited. Objective of this study was to evaluate virological outcomes of second-line ART...
10.
Tsertsvadze T, Chkhartishvili N, Dvali N, Karchava M, Chokoshvili O, Tavadze L, et al.
Int J STD AIDS
. 2014 Mar;
25(13):913-20.
PMID: 24671716
The knowledge of HIV incidence is essential to better understand patterns of HIV transmission. We estimated HIV incidence over 2010-2012 in the eastern European country of Georgia. Mathematical modeling using...